Jim Mazzala
Head of Investor Relations
Replay available
Outset Medical, Inc. (NASDAQ: OM) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

Head of Investor Relations
Chair and Chief Executive Officer
EVP of Commercial
Chief Financial Officer
Analyst, Stifel
Analyst, TD Cowen
Thank you for standing by. My name is Liz and I'll be your conference operator today. At this time, I would like to welcome everyone to the outset medical first quarter, 2026 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, Simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again. Thank you. I would now like to turn the call over to Jim Mazzala, Head of Investor Relations. Please go ahead. Good afternoon, everyone, and welcome to Outset Medical's first quarter 2026 earnings call. Today's speakers are Leslie Trigg, Chair and Chief Executive Officer, Derrick Elliott, EVP of Commercial, and Renee Guyetta, Chief Financial Officer. The company issued a news release after the close of the market today, which can be found on the investor pages of OutsetMedical.com. This call is being recorded and will be archived on the investor section of the Outset Medical website. All forward-looking statements made during today's call are intended to be protected under the Private Securities Litigation Reform Act of 1995. Outset assumes no obligation to update these statements. For a list and description of the risks and uncertainties associated with the business, please refer to Outset's public filings with the Securities and Exchange Commission, including its latest annual and quarterly reports. Thanks, Jim. Good afternoon, everyone, and thank you for joining us. The first quarter reflected consistent execution across console utilization, new customer additions, gross margin expansion, and disciplined cash management. While variability ...